atherosclerotic plaque therapeutics (Zydus-Cadila)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameatherosclerotic plaque therapeutics (Zydus-Cadila)
Drug Alias Nameatherosclerosis therapeutics (Zydus-Cadila)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArteriosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZydus Cadila
Active IndicationsN/A
Inactive IndicationsArteriosclerosis

Other Information

ATC CodeN/A
Related LinksN/A